Our Products

GLP-1 analogue

Download the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) for our GLP-1 analogue product Saxenda® .

Saxenda® (liraglutide injection 3mg)                        
PIP Code            
SmPC
Saxenda® 5 x 3 ml pen 402-8676 PIL

 


Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ By reporting side effects, you can help provide more information on the safety of this medicine.

This medicine is subject to additional safety monitoring.  This will allow quick identification of new safety information.  You can help by reporting any side effects you may get.  See https://yellowcard.mhra.gov.uk/ for how to report side effects.

 

This page is intended for members of the UK public
UK19SX00050 September 2019